Eli Lilly and Company v. Brenner

248 F. Supp. 402, 147 U.S.P.Q. (BNA) 442, 1965 U.S. Dist. LEXIS 9657
CourtDistrict Court, District of Columbia
DecidedDecember 6, 1965
DocketC. A. 2817-64
StatusPublished
Cited by11 cases

This text of 248 F. Supp. 402 (Eli Lilly and Company v. Brenner) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eli Lilly and Company v. Brenner, 248 F. Supp. 402, 147 U.S.P.Q. (BNA) 442, 1965 U.S. Dist. LEXIS 9657 (D.D.C. 1965).

Opinion

JACKSON, District Judge.

This is a civil action to obtain a patent brought by plaintiff, assignee of the patent application in suit, against defendant in his official capacity as Commissioner of Patents, according to the provisions of 35 U.S.C. § 145.

Plaintiff’s assignor, Richard T. Ra-pala, filed an application for patent, entitled “Novel Pregnenolone Acetonides”, on July 27, 1961, and the Patent Office identified the application as Serial No. 127,115. In the course of prosecution of this application, all the claims were finally rejected by the Examiner as un-patentable over a United States patent of Feather et al., patent No. 3,021,345, which was granted February 13, 1962, on an application for patent actually filed in the United States on September 19, 1960. Prior to the grant of this patent, Feather et al. properly claimed the right of priority of a corresponding patent application filed in the British Patent Office on September 24, 1959, and a certi *407 fied copy of this counterpart British application for the same invention was filed in the United States Patent Office.

Thus, the British and American filing dates for the respective Feather et al. patent applications were both prior to the actual filing date of Rapala’s United States application. Faced with this fact situation, Rapala filed an affidavit under Rule 181 of the Patent Office Rules of Practice in order to prove an actual reduction to practice of his claimed invention in this country prior to the actual filing date of the Feather et al. United States patent application, September 19, 1960. However, Rapala did not prove an actual reduction to practice of his invention in this country prior to September 24, 1959, the filing date of the Feather et al. British patent application. Since Rapala made no attempt in the Patent Office to antedate the Feather et al. British application date, it must be presumed that he is unable to do so, especially since plaintiff has made no offer to prove in this Court a date of actual reduction to practice in this country by Rapala prior to September 24, 1959. If plaintiff were able to prove this, it would have made such an offer of proof, since a civil action under 35 U.S.C. § 145 is in the nature of a trial de novo, and a plaintiff is not bound by the record established by proceedings in the Patent Office. Moreover, both plaintiff and defendant in the present case agree that there is no genuine issue as to any material fact and both parties have moved for summary judgment pursuant to Rule 56 of the Federal Rules of Civil Procedure.

Therefore, there is no question whatsoever that the relationship of critical dates is that Rapala proved a date of invention by actual reduction to practice of his claimed invention in this country at some time during the time interval of nearly one year between the filing date of the Feather et al. British application, September 24, 1959, and the actual filing date of the counterpart Feather et al. United States application, September 19, 1960. At this point, it is worthy of mention that a date of invention may be established by any one of at least three means, namely: (1) actual reduction to practice, wherein the invention is made as a matter of fact in this country 1 ; (2) constructive reduction to practice, wherein the invention is made as a matter of law in this country by filing an appropriate application in the United States Patent Office; and (3) constructive reduction to practice wherein the invention is made as a matter of law in this country by filing an appropriate application in a foreign country, then subsequently filing within one year an application in the United States Patent Office, which subsequent application is entitled to the full benefit of the earlier filing date in the foreign country for essentially all purposes, 2 if and provided that the full requirements of 35 U.S.C. § 119 are met.

It should also be mentioned that invention itself consists of two aspects, conception and reduction to practice. If Rapala had been able to prove conception of his invention prior to the British filing date of Feather et al., coupled with proof ■ of due diligence on the part of Rapala from a time just prior to this September 24, 1959 British filing date until Rapala’s reduction to practice during the interval between the Feather et al. British and American filing dates, then this reference, on the facts of this case, would have been removed for all purposes. Since no questions of conception coupled with due diligence are raised *408 in this case, this constitutes sufficient discussion of these factors.

The important question to be settled in this case is one of first impression in this Court. The issue may be stated to be whether, in a situation where a foreign inventor has been granted a United States patent on a United States patent application which is entitled under 35 U.S.C. § 119 to the benefit of an earlier application filing date in a foreign country, this United States patent is available as a reference under 35 U.S.C. § 102(e) 3 for all disclosed subject matter, whether claimed or unclaimed, as of the filing date of the earlier foreign application. This Court agrees with defendant and holds that the foreign filing date is the effective reference date as to all subject matter which is disclosed, whether claimed or not, in the foreign application, to the extent that such disclosures are brought forward and included in both the United States application and the United States patent granted on this application, the latter, of course, being the basis for a 35 U.S.C. § 102(e) rejection.

An important related question is whether another inventor, by proving a date of invention in this country, by either actual or constructive reduction to practice, 4 during the time interval between the foreign filing date and the actual United States filing date of a foreign inventor’s patent applications the foreign inventor’s United States application being entitled under 35 U.S.C. § 119 to benefit of the earlier filing date of the foreign application, can thereby remove the foreign inventor’s United States patent as a reference.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Municipal Mutual Insurance v. Mangus
443 S.E.2d 455 (West Virginia Supreme Court, 1994)
United States v. Golden Acres, Inc.
702 F. Supp. 1097 (D. Delaware, 1988)
Stein Associates, Inc. v. Heat and Control, Inc.
748 F.2d 653 (Federal Circuit, 1984)
Charles E. Ortman, Jr. v. Stanray Corporation
371 F.2d 154 (Seventh Circuit, 1967)
James Francis Smith v. State of Maryland
362 F.2d 763 (Fourth Circuit, 1966)

Cite This Page — Counsel Stack

Bluebook (online)
248 F. Supp. 402, 147 U.S.P.Q. (BNA) 442, 1965 U.S. Dist. LEXIS 9657, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eli-lilly-and-company-v-brenner-dcd-1965.